Concepedia

Andrea Favre-Bulle

AF

Statistics

Publications

4

Citations

52

H-Index

4

Active since

2022

Affiliations

MSD (Switzerland)(Current)

University of Basel

Merck & Co., Inc., Rahway, NJ, USA (United States)

Andrea Favre-Bulle is an author at MSD (Switzerland) specializing in oncology, cost-effectiveness comparison, and cost-effectiveness modeling.

Publications per year

2022–2023

4

Publications

4

Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery

Ilias Gountas, Andrea Favre-Bulle, Kunal Saxena et al. · Vaccines · 2023 · 16 citations · Full text

Public Affairs, Health Policy, Preventive Medicine +17

Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland

Andrea Favre-Bulle, Min Huang, Amin Haiderali et al. · PharmacoEconomics - Open · 2023 · 13 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Understanding physician’s knowledge and perception of chronic cough in Switzerland

Jörg D. Leuppi, Patrik Guggisberg, Daniel Koch et al. · Current Medical Research and Opinion · 2022 · 12 citations · Full text

Medicine, Health Sciences, Internal Medicine +12

Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland

Andrea Favre-Bulle, Goran Benčina, Shujing Zhang et al. · Journal of Medical Economics · 2023 · 11 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

1–4 of 4